Traduction de «Hypersomnia related to a known organic factor » (Anglais → Français) :

Definition: Hypersomnia is defined as a condition of either excessive daytime sleepiness and sleep attacks (not accounted for by an inadequate amount of sleep) or prolonged transition to the fully aroused state upon awakening. In the absence of an organic factor for the occurrence of hypersomnia, this condition is usually associated with mental disorders.

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include sel ...[+++]f-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

I think you are right in that there is an element of preserving some protectionist policy in terms of the speed at which traits are approved, but there is no doubt that there is a strong and vocal population who will never be convinced that they want to consume genetically modified, just as there are people who prefer to eat organic food as opposed to food grown with the use of crop-protection products, even though again there is no peer-reviewed science that says we have known risk factors.

We recognize that the safety issues related to genetically modified organisms are in fact the same as those already in the food supply: the potential for toxicity, for anti-nutritional factors, for allergenicity, the potential for those foods to be contaminated.

It does relate to a known threat, including the knowledge that we have that Canadians of Somali descent, for example, have returned to take part in the activities of an Al Qaeda linked organization called al Shabaab.

For substances related on a molecular level to known organ-specific toxicants (e.g. neurotoxicity), additional relevant parameters should ideally be examined in the context of a 28-day or 90-day study in lieu of a stand-alone, e.g. neurotoxicity study.